Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Amplia Therapeutics ( (AU:ATX) ) has shared an announcement.
Amplia Therapeutics Limited announced a proposed issue of securities, including a securities purchase plan and a placement, with a total of 107,673,920 ordinary fully paid securities to be issued. This move is aimed at raising capital to support the company’s ongoing projects and strategic initiatives, potentially enhancing its market position and providing opportunities for growth.
More about Amplia Therapeutics
Amplia Therapeutics Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is primarily engaged in advancing treatments for diseases with significant unmet medical needs.
Average Trading Volume: 6,618,883
Technical Sentiment Signal: Buy
Current Market Cap: A$110.8M
See more data about ATX stock on TipRanks’ Stock Analysis page.